Genetic Epidemiology of Prostate Cancer
نویسنده
چکیده
.........................................................................................................................6 Original papers ..............................................................................................................7 Abrevations....................................................................................................................8 Introduction ...................................................................................................................9 Incidence....................................................................................................................9 Risk factors ..............................................................................................................10 Diet ......................................................................................................................10 Hormonal and other factors .................................................................................10 Evidence of inherited susceptibility to prostate cancer ...........................................11 Case-control and cohort studies...........................................................................11 Twin studies.........................................................................................................11 Family-based segregation analyses .....................................................................12 Definition of hereditary prostate cancer ..............................................................14 Malignancies associated with HPC .........................................................................14 Gene mapping..........................................................................................................16 Human genetics and recombination.....................................................................16 Linkage analysis ..................................................................................................16 Linkage analyses of prostate cancer ........................................................................18 Prostate cancer susceptibility genes.........................................................................20 RNASEL..............................................................................................................20 MSR1...................................................................................................................21 HPC2/ELAC2......................................................................................................22 Other candidate genes..............................................................................................22 Aims.............................................................................................................................24 Material and methods ..................................................................................................25 HPC families ascertained for linkage analysis (Paper I, II, and IV)........................25 Patients with prostate cancer and controls (Paper III) .............................................26 Cohort of relatives of patients affected with HPC (Paper IV).................................27 Genotyping ..............................................................................................................28 Genome-wide markers (Paper I and IV)..............................................................28 Markers at 8p22-23 (Paper II) .............................................................................28 Sequence variants of the RNASEL gene (Paper III) ...........................................28 Statistical analysis....................................................................................................30 Linkage analysis (Paper I, II and IV)...................................................................30 Test for HWE (Paper III).....................................................................................31 Association analysis (Paper III)...........................................................................31 Haplotype analysis (Paper III) .............................................................................31
منابع مشابه
The Roles of Long non-coding RNAs (lncRNA) in Prostate Cancer
Background & Objective: Prostate cancer is a compound condition in which gene expression has altered. Several surveys have revealed that genetic components have been involved in prostate cancer progression. Findings proposed that they can modify a noteworthy portion of disposing of elements, which is associated to the developing prostate cancer in protein coding sequences. The purpose of this r...
متن کاملژنتیک مولکولی، تشخیص، پیشگیری و ژن درمانی در سرطان پروستات: مقاله مروری
The prostate is a small gland located below the bladder and upper part of the urethra. In developed countries prostate cancer is the second common cancer (after skin cancer), and also the second leading cause of cancer death (after lung cancer) among men. The several studies have been shown prostate cancer familial aggregation. The main reason for this aggregation is inheritance included genes....
متن کاملThe IGSF1, Wnt5a, FGF14, and ITPR1 Gene Expression and Prognosis Hallmark of Prostate Cancer
Background: Prostate cancer is considered as the second leading cause of cancer related death in men worldwide and the third frequent cancer among Iranian men. Despite the use of PSA as the only biomarker for early diagnosis of prostate cancer, its application in clinical settings is under debate. Therefore, the introduction of new molecular markers for early detection of prostate cancer is nee...
متن کاملWhat is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels?
Abstract Background: Regarding the variety of tests present for detecting and also screening prostate cancer and also bearing in mind the advantages and disadvantages of these tests we decided to re-evaluate these tests (total prostate specific antigen and all of its modifications) in detecting prostate cancer in men with intermediate serum PSAlevels. Methods: Following a cross se...
متن کاملBiomarkers in Prostate Cancer Epidemiology
Understanding the etiology of a disease such as prostate cancer may help in identifying populations at high risk, timely intervention of the disease, and proper treatment. Biomarkers, along with exposure history and clinical data, are useful tools to achieve these goals. Individual risk and population incidence of prostate cancer result from the intervention of genetic susceptibility and exposu...
متن کاملQSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer
The 17β-HSD3 enzyme plays a key role in treatment of prostate cancer and small inhibitorscan be used to efficiently target it. In the present study, the multiple linear regression (MLR),and support vector machine (SVM) methods were used to interpret the chemical structuralfunctionality against the inhibition activity of some 17β-HSD3inhibitors. Chemical structuralinformation were described thro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2004